Treating Benign Conditions with Radiation Therapy Including Dupuytrens disease and Plantar fasciitis Q. Did you know GenesisCare treat benign conditions with radiation therapy to reduce the pain associated with degenerative or inflammatory conditions? A. Radiation therapy may be an appropriate treatment option for patients. There is now a large and growing body of clinical research to demonstrate that radiation therapy, often called radiotherapy, can be as effective as traditional treatment techniques across a range of degenerative or inflammatory musculoskeletal indications. These include plantar fasciitis, Dupuytren’s Contracture disease / plantar fibromatosis, Achilles tendinopathy, rotator cuff syndrome and tennis elbow. Established treatments, anti-inflammatory drugs, steroid injections and/or physiotherapy, have shown to have variable effectiveness on these conditions. In some cases, randomized trials have demonstrated that radiation therapy produces superior outcomes.1, 2, 3, 4 For example, a clinical trial showed that patients treated with radiation therapy for plantar fasciitis had improved pain control with radiation therapy compared with steroid injections.5 Although the exact mechanisms are unclear, it is thought that radiation therapy works by exerting an antiinflammatory or anti-proliferative effect to reduce pain and swelling. www.genesiscancercareqld.com.au Radiation treatments can be delivered in as few as six noninvasive sessions. Each session takes around 20 minutes and has minimal risks. All treatments are delivered safely and effectively with modern equipment and using the latest proven techniques. There may be some mild redness of the skin immediately following treatment, but this usually disappears over 2-3 weeks. Anecdotally, around 80% of our patients report some resolution of pain, and about one third state that the pain is completely controlled after treatment. Why choose radiation therapy at GenesisCare? • No waiting lists • Treatment for both public and private patients • Highly affordable with cost effective treatment options using the latest VMAT technology • Minimal risk - doses are delivered in accordance with the best international experience • Superior treatment alternatives for benign conditions with unique outcomes compared to established treatments
John Flynn Heartbeat Newsletter Autumn 2017
To see the actual publication please follow the link above